These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23253550)

  • 21. Paclitaxel-eluting balloon: from bench to bed.
    De Labriolle A; Pakala R; Bonello L; Lemesle G; Scheinowitz M; Waksman R
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):643-52. PubMed ID: 19309715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unprotected left main stenting in the real world: five-year outcomes of the French Left Main Taxus registry.
    Mylotte D; Meftout B; Moynagh A; Vaquerizo B; Darremont O; Silvestri M; Louvard Y; Leymarie JL; Morice MC; Lefèvre T; Garot P
    EuroIntervention; 2012 Dec; 8(8):970-81. PubMed ID: 23014945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coronary Stent Failure: Fracture, Compression, Recoil, and Prolapse.
    Wiktor DM; Waldo SW; Armstrong EJ
    Interv Cardiol Clin; 2016 Jul; 5(3):405-414. PubMed ID: 28582037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Various optical coherence tomographic findings in restenotic lesions after sirolimus-eluting stent implantation.
    Takano M; Xie Y; Murakami D; Inami S; Yamamoto M; Ohba T; Seino Y; Mizuno K
    Int J Cardiol; 2009 May; 134(2):263-5. PubMed ID: 18403032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracoronary optical coherence tomography for the assessment of in-stent restenosis.
    Rayoo R; Tuer Z; Sharma N; Barlis P
    Heart Lung Circ; 2011 May; 20(5):332-5. PubMed ID: 21185781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute thrombotic occlusion or intramural hematoma: only IVUS can tell for sure.
    Baquero GA; Gilchrist IC
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):768-9. PubMed ID: 24167051
    [No Abstract]   [Full Text] [Related]  

  • 28. Stent thrombosis following 2 drug-eluting stent implantations for coronary bifurcation lesion: a single-center analysis.
    Gao Z; Xu B; Yang Y; Chen J; Qiao S; Li JJ; Qin X; Wu Y; Yao M; Yuan J; Chen J; Liu H; Dai J; Gao RL
    J Interv Cardiol; 2010 Aug; 23(4):346-51. PubMed ID: 20718906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term follow-up evaluation after sirolimus-eluting stent implantation by optical coherence tomography: do uncovered struts persist?
    Takano M; Yamamoto M; Inami S; Murakami D; Seimiya K; Ohba T; Seino Y; Mizuno K
    J Am Coll Cardiol; 2008 Mar; 51(9):968-9. PubMed ID: 18308167
    [No Abstract]   [Full Text] [Related]  

  • 30. Unexpected coronary perforation following adjunctive balloon postdilation after overlapping drug-eluting stent implantation rescued by successful stent graft implantation.
    Suh SY; Rha SW; Jin Z; Minami Y; Chen K; Na JO; Choi CU; Kim JW; Kim EJ; Park CG; Seo HS; Oh DJ
    Int J Cardiol; 2009 Feb; 132(1):e11-3. PubMed ID: 17996967
    [No Abstract]   [Full Text] [Related]  

  • 31. Serial assessment of coronary artery response to paclitaxel-eluting stents using optical coherence tomography.
    Guagliumi G; Bezerra HG; Sirbu V; Ikejima H; Musumeci G; Biondi-Zoccai G; Lortkipanidze N; Fiocca L; Capodanno D; Wang W; Tahara S; Vassileva A; Matiashvili A; Valsecchi O; Costa MA
    Circ Cardiovasc Interv; 2012 Feb; 5(1):30-8. PubMed ID: 22298797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed coverage in malapposed and side-branch struts with respect to well-apposed struts in drug-eluting stents: in vivo assessment with optical coherence tomography.
    Gutiérrez-Chico JL; Regar E; Nüesch E; Okamura T; Wykrzykowska J; di Mario C; Windecker S; van Es GA; Gobbens P; Jüni P; Serruys PW
    Circulation; 2011 Aug; 124(5):612-23. PubMed ID: 21768536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lower risk of stent thrombosis and restenosis with unrestricted use of 'new-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
    Sarno G; Lagerqvist B; Fröbert O; Nilsson J; Olivecrona G; Omerovic E; Saleh N; Venetzanos D; James S
    Eur Heart J; 2012 Mar; 33(5):606-13. PubMed ID: 22232428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.
    Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of optical coherence tomography guided percutaneous coronary intervention to assess stent malapposition in de-novo coronary lesions.
    Ratheesh KJ; Jaitly S; Vijayvergiya R
    Indian Heart J; 2018; 70(2):328-329. PubMed ID: 29716717
    [No Abstract]   [Full Text] [Related]  

  • 36. Restenosis in bare metal and drug-eluting stents: distinct mechanistic insights from histopathology and optical intravascular imaging.
    Byrne RA; Joner M; Tada T; Kastrati A
    Minerva Cardioangiol; 2012 Oct; 60(5):473-89. PubMed ID: 23018428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden.
    James SK; Stenestrand U; Lindbäck J; Carlsson J; Scherstén F; Nilsson T; Wallentin L; Lagerqvist B;
    N Engl J Med; 2009 May; 360(19):1933-45. PubMed ID: 19420363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drug-eluting stents in multivessel coronary artery disease: Was one of the important fortresses of surgery conquered?].
    Okmen AS; Okmen E
    Anadolu Kardiyol Derg; 2009 Aug; 9(4):325-30. PubMed ID: 19666436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neointimal coverage on drug-eluting stent struts crossing side-branch vessels using optical coherence tomography.
    Her AY; Lee BK; Shim JM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Am J Cardiol; 2010 Jun; 105(11):1565-9. PubMed ID: 20494663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spatial distribution of neo-intimal hyperplasia 6 months after zotarolimus-eluting stent implantation, analysed by optical coherence tomography.
    Souteyrand G; Levesque S; Ouchchane L; Sarry L; Eschalier R; Lusson JR; Motreff P
    Arch Cardiovasc Dis; 2011 Mar; 104(3):147-54. PubMed ID: 21497303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.